The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 25, 2016

Filed:

May. 19, 2015
Applicants:

Chao Chen, Shanghai, CN;

Haibing Deng, Shanghai, CN;

Haibing Guo, Shanghai, CN;

Feng He, Shanghai, CN;

Lei Jiang, Shanghai, CN;

Fang Liang, Shanghai, CN;

Yuan MI, Shanghai, CN;

Huixin Wan, Shanghai, CN;

Yao-chang Xu, Shanghai, CN;

Hongping Yu, Shanghai, CN;

Ji Yue Zhang, Shanghai, CN;

Inventors:

Chao Chen, Shanghai, CN;

Haibing Deng, Shanghai, CN;

Haibing Guo, Shanghai, CN;

Feng He, Shanghai, CN;

Lei Jiang, Shanghai, CN;

Fang Liang, Shanghai, CN;

Yuan Mi, Shanghai, CN;

Huixin Wan, Shanghai, CN;

Yao-Chang Xu, Shanghai, CN;

Hongping Yu, Shanghai, CN;

Ji Yue Zhang, Shanghai, CN;

Assignee:

NOVARTIS AG, Basel, CH;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/00 (2006.01); A61K 31/551 (2006.01); C07D 471/04 (2006.01); C07D 519/00 (2006.01); A61K 31/437 (2006.01); A61K 31/496 (2006.01); A61K 31/5377 (2006.01); A61K 31/5513 (2006.01); A61K 45/06 (2006.01); C07D 491/107 (2006.01); A61K 31/4709 (2006.01);
U.S. Cl.
CPC ...
A61K 31/551 (2013.01); A61K 31/437 (2013.01); A61K 31/4709 (2013.01); A61K 31/496 (2013.01); A61K 31/5377 (2013.01); A61K 31/5513 (2013.01); A61K 45/06 (2013.01); C07D 471/04 (2013.01); C07D 491/107 (2013.01); C07D 519/00 (2013.01);
Abstract

The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).


Find Patent Forward Citations

Loading…